Back to Search Start Over

Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A 2A Receptor.

Authors :
Comeo E
Kindon ND
Soave M
Stoddart LA
Kilpatrick LE
Scammells PJ
Hill SJ
Kellam B
Source :
Journal of medicinal chemistry [J Med Chem] 2020 Mar 12; Vol. 63 (5), pp. 2656-2672. Date of Electronic Publication: 2020 Jan 09.
Publication Year :
2020

Abstract

Among class A G protein-coupled receptors (GPCR), the human adenosine A <subscript>2A</subscript> receptor (hA <subscript>2A</subscript> AR) remains an attractive drug target. However, translation of A <subscript>2A</subscript> AR ligands into the clinic has proved challenging and an improved understanding of A <subscript>2A</subscript> AR pharmacology could promote development of more efficacious therapies. Subtype-selective fluorescent probes would allow detailed real-time pharmacological investigations both in vitro and in vivo. In the present study, two families of fluorescent probes were designed around the known hA <subscript>2A</subscript> AR selective antagonist preladenant (SCH 420814). Both families of fluorescent antagonists retained affinity at the hA <subscript>2A</subscript> AR, selectivity over all other adenosine receptor subtypes and allowed clear visualization of specific receptor localization through confocal imaging. Furthermore, the Alexa Fluor 647-labeled conjugate allowed measurement of ligand binding affinities of unlabeled hA <subscript>2A</subscript> AR antagonists using a bioluminescence resonance energy transfer (NanoBRET) assay. The fluorescent ligands developed here can therefore be applied to a range of fluorescence-based techniques to further interrogate hA <subscript>2A</subscript> AR pharmacology and signaling.

Details

Language :
English
ISSN :
1520-4804
Volume :
63
Issue :
5
Database :
MEDLINE
Journal :
Journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
31887252
Full Text :
https://doi.org/10.1021/acs.jmedchem.9b01856